These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 7316045)

  • 1. Mastodynia due to fibrocystic disease of the breast controlled with thyroid hormone.
    Estes NC
    Am J Surg; 1981 Dec; 142(6):764-6. PubMed ID: 7316045
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of benign breast disease with bromocriptine.
    Mussa A; Dogliotti L
    J Endocrinol Invest; 1979; 2(1):87-91. PubMed ID: 489922
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Prolactin levels and indicators of breast cancer risk in women with mastopathy].
    Teter J; Paszko Z; Gadomska H; Mach S; Kwiatkowska E
    Nowotwory; 1982; 32(4):193-200. PubMed ID: 7186116
    [No Abstract]   [Full Text] [Related]  

  • 4. Clinical trial of danazol for benign breast disease.
    Baker HW; Snedecor PA
    Am Surg; 1979 Nov; 45(11):727-9. PubMed ID: 391113
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Mastodynia and fibrocystic disease of the breast. Perspectives and methods of medical treatment].
    van Bogaert LJ
    J Gynecol Obstet Biol Reprod (Paris); 1986; 15(6):805-11. PubMed ID: 3794218
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aspects of fibrocystic disease of the breast. Treatment with danazol.
    Humphrey LJ; Estes NC
    Postgrad Med J; 1979; 55 Suppl 5():48-51. PubMed ID: 395520
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of benign fibrocystic disease of the breast with 2-bromo-alpha-ergocryptine (CB 154).
    Santoro C; Cappa M; Moretti C; Fabbri A; La Vecchia V; Romano Marcellino L; Fraioli F
    Int J Clin Pharmacol Ther Toxicol; 1982 Oct; 20(10):479-81. PubMed ID: 6815107
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Treatment of mastopathy with cyclic mastodynia: clinical results and hormone profile].
    Kubista E; Müller G; Spona J
    Gynakol Rundsch; 1986; 26(2):65-79. PubMed ID: 3525344
    [No Abstract]   [Full Text] [Related]  

  • 9. [Clinical comparision of alpha dihydroergocryptine against cabergoline in the treatment of the fibrocystic mastopathy].
    Castillo-Huerta E; Garibay-Valencia M; Mirabent-González F
    Ginecol Obstet Mex; 2013 Jul; 81(7):370-6. PubMed ID: 23971383
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Bromocriptine in fibro-cystic mastopathy].
    Marzetti L; Framarino ML; Dei Malatesta ML; Aragona C; De Angelis R
    Riv Ital Ginecol; 1980; 59(4-5):357-64. PubMed ID: 7313397
    [No Abstract]   [Full Text] [Related]  

  • 11. Hormonal profile of benign breast disease and premenstrual mastodynia.
    Gorins A; Cordray JP
    Eur J Gynaecol Oncol; 1984; 5(1):1-10. PubMed ID: 6698047
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum prolactin levels in patients with fibrocystic breast disease.
    Peters F; Schuth W; Scheurich B; Breckwoldt M
    Obstet Gynecol; 1984 Sep; 64(3):381-5. PubMed ID: 6431348
    [TBL] [Abstract][Full Text] [Related]  

  • 13. THE ROLE OF E2/P RATIO IN THE ETIOLOGY OF FIBROCYSTIC BREAST DISEASE, MASTALGIA AND MASTODYNIA.
    Brkić M; Vujović S; Ivović M; Tančić Gajić M; Marina L; Franić Ivanišević M; Franić D
    Acta Clin Croat; 2018 Dec; 57(4):756-761. PubMed ID: 31168213
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Danazol treatment of severely symptomatic fibrocystic breast disease and long-term follow-up--the Hjørring project.
    Tobiassen T; Rasmussen T; Döberl A; Rannevik G
    Acta Obstet Gynecol Scand Suppl; 1984; 123():159-76. PubMed ID: 6594009
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclic progestin therapy for the management of mastopathy and mastodynia.
    Winkler UH; Schindler AE; Brinkmann US; Ebert C; Oberhoff C
    Gynecol Endocrinol; 2001 Dec; 15 Suppl 6():37-43. PubMed ID: 12227885
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Treatment of mastopathies with cyclic mastodynia. Clinical results and hormonal profiles].
    Kubista E; Müller G; Spona J
    Rev Fr Gynecol Obstet; 1987 Apr; 82(4):221-7. PubMed ID: 3589362
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Danazol treatment of chronic cystic mastopathy: a clinical and hormonal evaluation.
    Dhont M; Delbeke L; van Eyck J; Voorhoof L
    Postgrad Med J; 1979; 55 Suppl 5():66-70. PubMed ID: 395523
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Antiprolactin therapy in the treatment of benign lesions of the breast. Comparison of bromocryptine and methergoline].
    Mussa A; Sandrucci S; Dogliotti L
    Minerva Med; 1979 Nov; 70(51):3493-8. PubMed ID: 522987
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Treatment of mastodynia using Monogest].
    Vachousek J; Kratochvíl B; Smejkal V; Güttner V
    Cesk Gynekol; 1989 Mar; 54(2):110-2. PubMed ID: 2731238
    [No Abstract]   [Full Text] [Related]  

  • 20. Danazol for benign breast disease.
    Nezhat C; Asch RH; Greenblatt RB
    Am J Obstet Gynecol; 1980 Jul; 137(5):604-7. PubMed ID: 7386553
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.